Brief: Clarity Pharmaceuticals Confirms No Supply Disruptions For Clinical Trials
07/06/2024 02:12
June 7 (Reuters) - Clarity Pharmaceuticals Ltd CU6.AX :
* CLARITY PHARMACEUTICALS LTD-CLARITY CONFIRMS NO SUPPLY
DISRUPTIONS FOR CLINICAL TRIALS
* CLARITY PHARMACEUTICALS LTD - TCT PRODUCTS &CLINICAL
DEVELOPMENT PROGRAMS USING COPPER-67 UNAFFECTED BY RECENT
SHORTAGE OF ACTINIUM-225
Source text for Eikon: ID:nASX1bLqwm
Further company coverage: CU6.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clarity Pharmaceuticals
See all newsBrief: Clarity Pharmaceuticals Signs Commercial Manufacturing Agreement
Brief: Clarity Signs A Large-Scale Manufacturing Supply Agreement For Copper-64 With Theragenics
Brief: Clarity Pharmaceuticals Signs A Large-Scale Manufacturing Supply Agreement
Australia's Clarity Pharmaceuticals rises on bagging cancer detection agent supply
Australia's Clarity Pharma surges as US FDA approves trial